Overview
Postaxial acrofacial dysostosis, also known as Miller syndrome or Genée-Wiedemann syndrome, is a rare genetic disorder characterized by distinctive craniofacial abnormalities combined with limb defects, particularly affecting the postaxial (ulnar/fibular) side of the extremities. It belongs to the group of acrofacial dysostoses, conditions that involve both facial and limb malformations. The craniofacial features include malar (cheekbone) hypoplasia, downslanting palpebral fissures, micrognathia (small lower jaw), cleft lip and/or cleft palate, coloboma (notching) of the lower eyelids, and cup-shaped or absent ears with associated conductive hearing loss. The limb abnormalities predominantly affect the postaxial rays and may include absence or hypoplasia of the fifth digits, shortening of the ulna and radius, and abnormalities of the fourth and fifth toes. Some patients may also have syndactyly or other skeletal anomalies. Miller syndrome is caused by biallelic pathogenic variants in the DHODH gene, which encodes dihydroorotate dehydrogenase, an enzyme essential for de novo pyrimidine biosynthesis. This was notably one of the first Mendelian disorders identified through exome sequencing. The condition is present at birth and severity can vary considerably among affected individuals. Management is multidisciplinary and symptomatic, involving craniofacial surgery for jaw and palate abnormalities, reconstructive surgery for limb defects, hearing aids or surgical correction for hearing loss, and speech therapy. Regular monitoring by a team including geneticists, plastic surgeons, orthopedic specialists, audiologists, and speech-language pathologists is recommended. There is currently no cure or disease-specific therapy available.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Postaxial acrofacial dysostosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Postaxial acrofacial dysostosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Postaxial acrofacial dysostosis.
Community
No community posts yet. Be the first to share your experience with Postaxial acrofacial dysostosis.
Start the conversation →Latest news about Postaxial acrofacial dysostosis
No recent news articles for Postaxial acrofacial dysostosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Postaxial acrofacial dysostosis
What is Postaxial acrofacial dysostosis?
Postaxial acrofacial dysostosis, also known as Miller syndrome or Genée-Wiedemann syndrome, is a rare genetic disorder characterized by distinctive craniofacial abnormalities combined with limb defects, particularly affecting the postaxial (ulnar/fibular) side of the extremities. It belongs to the group of acrofacial dysostoses, conditions that involve both facial and limb malformations. The craniofacial features include malar (cheekbone) hypoplasia, downslanting palpebral fissures, micrognathia (small lower jaw), cleft lip and/or cleft palate, coloboma (notching) of the lower eyelids, and cu
How is Postaxial acrofacial dysostosis inherited?
Postaxial acrofacial dysostosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Postaxial acrofacial dysostosis typically begin?
Typical onset of Postaxial acrofacial dysostosis is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Postaxial acrofacial dysostosis?
2 specialists and care centers treating Postaxial acrofacial dysostosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.